Clinical Trial Update: A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer [Phase 3]

View source ↗

Summary

A Phase 3 pivotal trial comparing the bioequivalence of oral Viagra (sildenafil) and a test sublingual sildenafil wafer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Sildenafil Sublingual Wafer (test formulation) (sildenafil)
• Viagra (Sildenafil)

Snippet

Sponsor: iX Biopharma Ltd. | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED